Furthermore, Ding et al. 43 point out that lncRNA-PVT1 is associated with tumor progression and can serve as a novel biomarker for predicting tumor recurrence in hepatocellular carcinoma-related patients. This evidence concerns the gene PVT1 and hepatocellular carcinoma.